TFPI
TFPI (Tissue Factor Pathway Inhibitor) a Kunitz-type serine protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. Inhibition of the encoded protein restores hemostasis in animal models of hemophilia. Diseases associated with TFPI include Hemophilia and Thrombosis.CAT | Product Name | Source | Product Overview | Target | Type | Datasheet | Size | Price |
---|---|---|---|---|---|---|---|---|
VAng-2766Lsx | Rhesus macaque TFPI Protein (Asp 29-Lys 282) [His] | HEK293 cells | Rhesus macaque TFPI protein, His tag, was expressed in human 293 cells. (Uniprot ID: Q28864) | TFPI | Tumor Antigens | ![]() |
50 µg | Inquiry |
VAng-2767Lsx | Biotinylated Human TFPI Protein (Asp 29-Lys 282) [His] | HEK293 cells | Biotinylated Human TFPI protein, His tag, primary amine labeling, was expressed in human 293 cells. (Uniprot ID: NP_006278.1) | TFPI | Tumor Antigens | ![]() |
25 µg | Inquiry |
VAng-2768Lsx | Human TFPI Protein (Asp 29-Lys 282) [His] | HEK293 cells | Human TFPI protein, His tag, was expressed in human 293 cells. (Uniprot ID: NP_006278.1) | TFPI | Tumor Antigens | ![]() |
50 µg | Inquiry |
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.